In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions

Journal of Lipid Research

Volumn 42, Issue 4, 2001, Pages 563-570

  Hedrick, C C ^a   Castellani, L W ^a   Wong, H ^a   Lusis, A J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Atherosclerosis; Lipoprotein; Paraoxonase; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ARTERIOSCLEROSIS; CELL ADHESION; CHOLESTEROL; DIET, ATHEROGENIC; ENDOTHELIUM, VASCULAR; HUMANS; LIPASE; LIPIDS; LIPOPROTEINS, HDL; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES;

EID: 0035059514     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
2. Lipoprotein metabolism: High density lipoprotein
3. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and atherosclerosis
4. Effect of platelet-activating factor acetylhydrolase on formation and action of minimally oxidized LDL
5. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
6. Expression of human apolipoprotein Al in transgenic mice results in reduced plasma levels of murine apolipoprotein AI and the appearance of two new high density lipoprotein size subclasses
7. Regression of atherosclerotic lesions by HDL plasma fraction in cholesterol-fed rabbits
8. A splice-junction mutation responsible for familial apolipoprotein AII deficiency
9. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
10. Human AII inhibits hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and CETP in transgenic mice
11. Atherosclerosis in transgenic mice overexpressing apolipoprotein AII
12. Influence of mouse apolipoprotein AII on plasma lipoproteins in transgenic mice
13. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition
14. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles
15. Mild dyslipidemia following targeted inactivation of the hepatic lipase gene
16. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification
17. Genetic factors controlling structure and expression of apolipoproteins B and E in mice
18. A stable radioactive substrate emulsion for assay of lipoprotein lipase
19. Mouse preheparin plasma contains high levels of hepatic lipase with low affinity, for heparin
20. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions
21. Different reactivities of high-density lipoprotein 2 subfractions with hepatic lipase
22. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/ endothelial interactions and evidence for their presence in vivo
23. Human monocyte:endothelial cell interaction in vitro
24. Modification of the Recalde method for the isolation of human monocytes
25. Human apolipoprotein AII is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: Evidence of a potentially relevant species-specific interaction with diet
26. Mice lacking serum paraoxonase are susceptible to organophophate toxicity and atherosclerosis
27. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein. A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
28. ApoAI inhibits foam cell formation in apoE-deficient mice after monocyte adherence to endothelium
29. Influence of the apoAII gene locus on HDL levels and fatty streak development in mice
30. Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strians NZB/BINJ and SM/J using a complete linkage map approach
31. ApoAII maintains HDL levels in part by inhibition of hepatic lipase. Studies in apoAII and hepatic lipase knockout mice
32. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein AII knockout mice suggest a complex role for apolipoprotein AII in atherosclerosis susceptibility
33. Relationships between the metabolism of high-density and very-low-density lipoproteins in man; studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity
34. Activities of lipoprotein lipase and hepatic triglyceride lipase in post heparin plasma of patients with low concentrations of HDL cholesterol
35. Overexpression of human apolipoprotein AII in mice induce hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
36. The influence of apolipoproteins on the hepatic-lipase-mediated hydrolysis of HDL phospholipid and triaclyglycerol
37. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females
38. Evidence for linkage of the apolipoprotein Ail locus to plasma apolipoprotein AII and FFA levels in mice and humans
39. Plasma lipoprotein lipids in relation to the Mspl polymorphism of the apolipoprotein Ail gene in Caucasian men
40. DNA polymorphisms of the apoAII and AI-CIII-AIV genes: A study in men selected for difference in HDL-C concentration